CA50785-4B - 0x0000000000006BEA
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
August 10, 2026 - 3:30pm
End Date:
September 29, 2026 - 10:00am
Study Details
Study Number: CA50785
Group Number: 4B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,500.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16
Study Schedule
Schedule Type: Short stays with returns
Study Length: Two - 3 Night Stays & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 7/27/2026 |
| Thursday | 7/30/2026 |
| Monday | 8/3/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 7/27/2026 |
| Thursday | 7/30/2026 |
| Monday | 8/3/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Monday | 8/10/2026 3:30:00 PM | Friday | 8/14/2026 10:00:00 AM | 1 | Lincoln |
| Check-In | Monday | 9/21/2026 3:30:00 PM | Friday | 9/25/2026 10:00:00 AM | 2 | Lincoln |
| Return | Tuesday | 9/29/2026 9:00:00 AM | Tuesday | 9/29/2026 10:00:00 AM | 2 | Lincoln |
